Enterprise Europe Network

The SME from Poland is looking for collaboration under the license agreement in biotechnological sector.

Country of origin:
External Id: 
Last update
Expiration date


Partner keyword: 
Biochemistry / Biophysics
Medical instruments
Pharmaceuticals/fine chemicals
Other medical/health related (not elsewhere classified)
Research and experimental development on biotechnology
Other research and experimental development on natural sciences and engineering
Other human health activities


A Polish biotechnological company develops proprietary drug formulas in the field of oncology, dermatology and autoimmune diseases. All their products are patented and protected. The SME is looking for partner from biotechnological sector to begin cooperation under license agreement.



The Polish company, located in south-west Poland was established in 2018 and is one of the innovative regional companies in the biotechnological trade.

The team of SME technologists has developed a proprietary technology for obtaining a universal transdermal therapeutic system. Thanks to the unique properties of the system, it is possible to increase the bioavailability of active substances by several times, allowing active substances to penetrate through skin barriers up to several centimetres, reaching soft tissues and bones. The unique transdermal system can be easily modified to achieve a targeted action in pathologically changed tissues.

The company products in the pipeline:
- Innovation technology: a transport system created on the basis of non-aggregating molecules to increase the surface area of the release of solid drug form.
- Drug candidate: local anesthetic ointment
- Drug candidate: tissue regeneration ointment
- Drug candidate: propriate drug for breast cancer treating

All products & technologies are protected by patent applications.

In connection with increasing company competition on the market, the SME plans to introduce new products to their customers. Therefore, the company is currently looking for industry partners to carry out the POC Phase project to connect the original system carrier with the partner's API (Active Pharmaceutical Ingredients) in terms of license agreement.

Advantages & innovations

Cooperation plus value: 
With more than thirty years of experience, the R&D company team is able to effectively create proprietary medicines, solve complex technological problems and create unique solutions to help people all over the world. The SME also provides research and development services for pharmaceutical, biotechnological, cosmetic and chemical companies from all over the world.

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
The company is ready to sell licenses for proprietary products protected by patent applications under license agreement. Licensee's role is using a innovation product of the company under a specific set of parameters. The SME is seeking partners with great potential, who in a responsible and comprehensive manner will engage in cooperation on projects / selected project. Potencial partner can be: - pharmaceutical companies - FMCG industry companies - manufacturers of medical and veterinary products

Type and size

Cooperation task: 
251-500,SME 51-250,>500


Dissemination sector group : 
Dissemination preferred : 
Austria, Belgium, Bulgaria, China, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Romania, Slovakia, Slovenia, South Korea, Spain, Sweden, United Kingdom, USA